Advancing Needleless Drug Delivery in Nigeria
A Strategic Opportunity for Partnership with Champions Pharmaceuticals
The Next Evolution in Drug Delivery
Needleless drug delivery represents the next evolution in modern medicine, offering a safe, efficient, and patient-friendly alternative to traditional injections. These technologies deliver medications through methods such as jet injectors, transdermal systems, inhalation, and microneedle patches, eliminating the need for conventional needles.
Needleless systems can still provide rapid and precise delivery, while reducing risks associated with needle use such as infections, needle-stick injuries, and improper disposal. They also improve patient compliance, particularly among populations with needle aversion.
Advances in pharmaceutical technology now allow a wide range of molecules — including vaccines, biologics, and hormones — to be delivered effectively without needles, making this approach increasingly viable for large-scale healthcare programs.
Importance of Needleless Therapies
Transitioning toward needleless delivery systems offers significant benefits across Nigeria's healthcare landscape.
Diabetes Management
Needleless insulin delivery systems can improve adherence for patients requiring daily treatment, reducing discomfort and long-term complications.
Pain Management
Alternative delivery formats for medications such as pentazocine, tramadol, codeine, and morphine can reduce dependency on injectable routes while maintaining effectiveness.
Vaccination Programs
Needleless vaccine delivery can enhance immunization coverage by simplifying administration, reducing fear, and improving safety during mass campaigns.
Public Health Impact
With an estimated 80,000 people who inject drugs (PWID) in Nigeria, needleless systems present an opportunity to reduce needle-related harm and disease transmission, support harm-reduction strategies, and improve public health safety through reduced needle circulation.
Alignment with National Health Programs
Champions Pharmaceuticals proposes to support Nigeria's healthcare modernization by aligning with initiatives led by the National Primary Health Care Development Agency (NPHCDA).
The NPHCDA is Responsible for:
- ✓ National immunization programs
- ✓ Vaccine-preventable disease control
- ✓ Expanding access to primary healthcare services
Integrating needleless delivery systems into these programs can enhance efficiency, safety, and reach across Nigeria's healthcare system.
Proposed Initiatives
Champions Pharmaceuticals proposes the following initiatives to advance needleless drug delivery across Nigeria.
Pilot Trial Program
Champions Pharmaceuticals will initiate a pilot program with the Ministry of Health through international partners, following required regulatory approvals including FDA authorization for applicable needleless technologies and associated therapies.
Operational Support
Provide needleless drug delivery equipment and infrastructure, program logistics and supply chain coordination, and technical and implementation support in collaboration with NPHCDA.
Global Health Alignment
This initiative aligns with global public health priorities supported by the World Health Organization (WHO), particularly in improving safe, equitable access to medicines and reducing healthcare risks.
Access to International Health Programs
Champions Pharmaceuticals aims to collaborate with international aid organizations and health programs across Africa.
Expand Access
Expand access to innovative, needleless therapies across Nigeria through integration with international health programs.
Strengthen National Programs
Support national immunization and treatment programs by modernizing delivery infrastructure and reducing needle-related risks.
Scalable Solutions
Deliver cost-effective and scalable healthcare solutions that make needleless therapies accessible to facilities nationwide.
A Transformational Opportunity for Nigeria's Healthcare
Needleless drug delivery represents a transformational opportunity for Nigeria's healthcare system. By reducing risks, improving patient compliance, and enhancing the scalability of treatment and vaccination programs, this approach complements and strengthens existing healthcare infrastructure.
Through collaboration with the Federal Ministry of Health, the NPHCDA, and global partners, Champions Pharmaceuticals is positioned to support Nigeria in adopting safer, more efficient drug delivery systems and improving health outcomes nationwide.
Interested in This Initiative?
Champions Pharmaceuticals welcomes strategic dialogue with healthcare stakeholders, government agencies, and international partners interested in advancing needleless drug delivery in Nigeria.
Contact Our Partnership Team